{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:41:16Z","timestamp":1789846876740,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.4158\/ep14104.or","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T22:44:57Z","timestamp":1402958697000},"page":"1165-1169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism"],"prefix":"10.1016","volume":"20","author":[{"given":"Hemal","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Trooskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Shapses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14104.OR_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Atkinson EJ, et al Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP14104.OR_bb0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Clinical practice. Asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14104.OR_bb0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primaryhyperparathyroidism and increased body weight: a meta-analysis","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14104.OR_bb0020","first-page":"548","article-title":"Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism","volume":"35","author":"Han","year":"2012","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14104.OR_bb0025","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4158\/EP12440.RA","article-title":"Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease","volume":"19","author":"Huang","year":"2013","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14104.OR_bb0030","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1210\/jc.2010-2781","article-title":"The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity","volume":"96","author":"Sukumar","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14104.OR_bb0035","doi-asserted-by":"crossref","first-page":"33098","DOI":"10.1074\/jbc.M611781200","article-title":"Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre\/osteoclasts","volume":"282","author":"Li","year":"2007","journal-title":"J Biol Chem."},{"key":"10.4158\/EP14104.OR_bb0040","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14104.OR_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archsurg.141.9.885","article-title":"The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism","volume":"141","author":"VanderWalde","year":"2006","journal-title":"Arch Surg."},{"key":"10.4158\/EP14104.OR_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/dmrr.637","article-title":"Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy","volume":"23","author":"Khaleeli","year":"2007","journal-title":"Diabetes Metab Res Rev."},{"key":"10.4158\/EP14104.OR_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","article-title":"Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?","volume":"162","author":"Anderson","year":"2011","journal-title":"Am Heart J."},{"key":"10.4158\/EP14104.OR_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","article-title":"Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism","volume":"137","author":"Nilsson","year":"2005","journal-title":"Surgery."},{"key":"10.4158\/EP14104.OR_bb0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effects of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14104.OR_bb0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4158\/EP10321.OR","article-title":"Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism","volume":"17","author":"Ishay","year":"2011","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14104.OR_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/155892501000500401","article-title":"Feasibility of electrospun polydioxanone monocyte chemotactic protein-1 (MCP-1) hybrid scaffolds as potential cellular homing devices","volume":"5","author":"Smith","year":"2010","journal-title":"J Engineered Fibers Fabrics."},{"key":"10.4158\/EP14104.OR_bb0080","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14104.OR_bb0085","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP14104.OR_bb0090","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.ijo.0803259","article-title":"Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters","volume":"30","author":"Kim","year":"2006","journal-title":"Int J Obes (Lond)."},{"key":"10.4158\/EP14104.OR_bb0095","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes."},{"key":"10.4158\/EP14104.OR_bb0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.ijo.0802839","article-title":"Monocyte che- moattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects","volume":"29","author":"Christiansen","year":"2005","journal-title":"Int J Obes (Lond)."},{"key":"10.4158\/EP14104.OR_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","article-title":"Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes","volume":"60","author":"Panee","year":"2012","journal-title":"Cytokine."},{"key":"10.4158\/EP14104.OR_bb0110","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/jbmr.1933","article-title":"Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone","volume":"28","author":"Tamasi","year":"2013","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP14104.OR_bb0115","doi-asserted-by":"crossref","first-page":"H2584","DOI":"10.1152\/ajpheart.00349.2002","article-title":"Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow","volume":"283","author":"Maus","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.4158\/EP14104.OR_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1155\/MI.2005.175","article-title":"Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction","volume":"2005","author":"Arakelyan","year":"2005","journal-title":"Mediators Inflamm."},{"key":"10.4158\/EP14104.OR_bb0125","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1073\/pnas.88.12.5252","article-title":"Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions","volume":"88","author":"Yla-Herttuala","year":"1991","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/Q233348703531065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:41Z","timestamp":1761515861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20419238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1530891X20419238"],"URL":"https:\/\/doi.org\/10.4158\/ep14104.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Monocyte Chemokine Protein-1 Levels Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14104.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}